M. Idamakanti, R. I. Bijjam, M. Kumar, and S. K. Mukkamalla, “Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review”, J Med Cases, vol. 16, no. 6, pp. 212–221, Jun. 2025, doi: 10.14740/jmc5136.